Provenance du réseau au premier degré de Charles P. du Mée
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Charles P. du Mée via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
| DIGNITANA AB | Medical Specialties | Director/Board Member Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Artimplant AB
 Artimplant AB Medical SpecialtiesHealth Technology Artimplant AB engages in research and development of biomaterials for solutions to problems in orthopedic, odontological and reconstructive surgery. It also involves in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The company was founded by Anders Cedronius in 1990 and is headquartered in Vastra Frolunda, Sweden. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| ALLENEX AB | Biotechnology | Chairman Corporate Officer/Principal | |
| New York University | College/University | Masters Business Admin | |
| University of Maryland | College/University | Undergraduate Degree | |
| University of Uppsala | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Chairman | |
| University of Stockholm | College/University | Masters Business Admin | |
| Royal Institute of Technology | College/University | Graduate Degree | |
| NIMUTAN AB (PUBL) | Household/Personal Care | Director/Board Member | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| Glaxo AB | Corporate Officer/Principal | ||
| WNTRESEARCH AB | Pharmaceuticals: Other | Chairman | |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Andreasson & Forsgren Elteknik AB | Director of Finance/CFO | ||
| OxyPharma AB | Chief Executive Officer | ||
Vivolux AB
 Vivolux AB BiotechnologyHealth Technology Vivolux AB develops biotechnology for anticancer drugs. The private company is based in Gothenburg, Sweden. | Biotechnology | President | |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
Artery Therapeutics, Inc.
 Artery Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Artery Therapeutics, Inc. is an American biotechnology company that operates in the field of medicine. The private company was founded by Hans Ageland. | Miscellaneous Commercial Services | Founder | |
| MENDUS AB | Biotechnology | Director/Board Member | |
| Vital Signs Sweden AB | Director/Board Member | ||
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
| LIPUM AB | Biotechnology | Chairman | |
| Ub-Consulting AB | Chief Executive Officer | ||
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Chairman | |
| ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
| Rooslien & Skoglund Ekonomi AB | Founder | ||
| Bioage AB | Chief Executive Officer | ||
| Trobio AB | Founder | ||
Ilama AB
 Ilama AB Financial ConglomeratesFinance Ilama AB provides investment services. | Financial Conglomerates | Director/Board Member | |
| RAILWAY METRICS AND DYNAMICS SWEDEN AB | Trucks/Construction/Farm Machinery | Director of Finance/CFO | |
Colzyx AB
 Colzyx AB Medical SpecialtiesHealth Technology Colzyx AB is a biotechnology company located in Lund, Sweden. The Swedish company specializes in wound care and have developed a new wound dressing called Woundcom. This innovative product not only accelerates wound healing but also has an antibacterial effect. The private company has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 947034. | Medical Specialties | Director/Board Member | |
| AMNIOTICS AB | Biotechnology | Director/Board Member | |
XNK Therapeutics AB
 XNK Therapeutics AB Pharmaceuticals: MajorHealth Technology XNK Therapeutics AB operates as a technology platform which leads research on NK cells at Karolinska Institutet in Stockholm. The company was founded in 2012 and is headquartered in Huddinge, Sweden. | Pharmaceuticals: Major | Chairman | |
| Bostadsrättsföreningen Gammelgården I Sälen | Chairman | ||
| Bostadsrättsföreningen åkermannen 42 | Director/Board Member | ||
| Ateljé Grön AB | Corporate Officer/Principal | ||
Daniel & Sebastian Byggentreprenad AB
 Daniel & Sebastian Byggentreprenad AB Engineering & ConstructionIndustrial Services Daniel & Sebastian Byggentreprenad AB provides building carpentry work services. The private company is based in Stockholm, Sweden. | Engineering & Construction | Corporate Officer/Principal | |
Rochs Sifferkontoret AB
 Rochs Sifferkontoret AB Miscellaneous Commercial ServicesCommercial Services Rochs Sifferkontoret AB provides accounting and bookkeeping services. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman | |
| Rooslien Ekonomikonsult AB | Director/Board Member | ||
| Q-Basic Education AB | Chairman | ||
| Grappa Interim Management AB | Director/Board Member | ||
| Prosalary International AB | Director/Board Member | ||
| CHOSA ONCOLOGY AB | Miscellaneous Commercial Services | Director/Board Member |
Statistiques
Internationale
| Suède | 46 |
| Etats-Unis | 6 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Consumer Non-Durables | 2 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 46 |
| Chairman | 21 |
| Corporate Officer/Principal | 14 |
| Independent Dir/Board Member | 10 |
| Chief Executive Officer | 8 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ingrid Atteryd Heiman | 24 |
| Gunnar Mattsson | 16 |
| Bengt Daniel Furberg | 16 |
| Ulf Björklund | 14 |
| Hans Ageland | 11 |
| Peter Rooslien | 10 |
| Martin Vidaeus | 6 |
- Bourse
- Insiders
- Charles P. du Mée
- Connexions Sociétés
